Vanguard Health Care ETF(VHT · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$283.49
- 52-Week Range
- $237.23 – $298.61
- YTD
- -1.82%
- IV Rank (30D)
- 12.3
- Straddle Price
- $13.25
- P/C Vol Ratio
- 0.54
Info
Vanguard Health Care ETF (VHT) ETF
- Exchange
- ARCX
- Inception
- 2004-01-26
- Has Options
- Yes
ETF Profile
holdings as of 2026-04-30
Holdings
400
AUM
$18.5B
Provider
Vanguard
Inception
2004-01-26
Exchange
ARCX
Data As Of
2026-04-30
Expense Ratio
0.09%
Dividend Yield
1.65%
Distribution
Quarterly
Recent distributions
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-03-24 | 2026-03-26 | $0.9940 | CD |
| 2025-12-17 | 2025-12-19 | $1.6654 | CD |
| 2025-09-24 | 2025-09-26 | $1.0765 | CD |
| 2025-06-26 | 2025-06-30 | $0.9619 | CD |
| 2025-03-25 | 2025-03-27 | $0.9396 | CD |
| 2024-12-18 | 2024-12-20 | $0.9188 | CD |
Asset Allocation
Top Holdings
top 50 of 400 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| LLY | Eli Lilly & Co. | 12.15% | Equity (US) | — |
| JNJ | Johnson & Johnson | 8.84% | Equity (US) | — |
| ABBV | AbbVie Inc. | 6.04% | Equity (US) | — |
| UNH | UnitedHealth Group Inc. | 5.43% | Equity (US) | — |
| MRK | Merck & Co. Inc. | 4.39% | Equity (US) | — |
| AMGN | Amgen Inc. | 3.02% | Equity (US) | — |
| TMO | Thermo Fisher Scientific Inc. | 2.91% | Equity (US) | — |
| GILD | Gilead Sciences Inc. | 2.63% | Equity (US) | — |
| ISRG | Intuitive Surgical Inc. | 2.63% | Equity (US) | — |
| ABT | Abbott Laboratories | 2.55% | Equity (US) | — |
| PFE | Pfizer Inc. | 2.46% | Equity (US) | — |
| BMY | Bristol-Myers Squibb Co. | 2.00% | Equity (US) | — |
| DHR | Danaher Corp. | 1.84% | Equity (US) | — |
| SYK | Stryker Corp. | 1.76% | Equity (US) | — |
| VRTX | Vertex Pharmaceuticals Inc. | 1.75% | Equity (US) | — |
| CVS | CVS Health Corp. | 1.71% | Equity (US) | — |
| MDT | Medtronic plc | 1.68% | Equity (US) | — |
| MCK | McKesson Corp. | 1.63% | Equity (US) | — |
| BSX | Boston Scientific Corp. | 1.38% | Equity (US) | — |
| ELV | Anthem Inc. | 1.32% | Equity (US) | — |
| CI | Cigna Corp. | 1.26% | Equity (US) | — |
| REGN | Regeneron Pharmaceuticals Inc. | 1.18% | Equity (US) | — |
| HCA | HCA Healthcare Inc. | 1.12% | Equity (US) | — |
| COR | AmerisourceBergen Corp. Class A | 0.92% | Equity (US) | — |
| ZTS | Zoetis Inc. | 0.82% | Equity (US) | — |
| EW | Edwards Lifesciences Corp. | 0.78% | Equity (US) | — |
| CAH | Cardinal Health Inc. | 0.74% | Equity (US) | — |
| IDXX | IDEXX Laboratories Inc. | 0.72% | Equity (US) | — |
| BDX | Becton Dickinson and Co. | 0.69% | Equity (US) | — |
| ALNY | Alnylam Pharmaceuticals Inc. | 0.66% | Equity (US) | — |
| A | Agilent Technologies Inc. | 0.53% | Equity (US) | — |
| RMD | ResMed Inc. | 0.51% | Equity (US) | — |
| WAT | Waters Corp. | 0.49% | Equity (US) | — |
| INSM | Insmed Inc. | 0.47% | Equity (US) | — |
| HUM | Humana Inc. | 0.46% | Equity (US) | — |
| BIIB | Biogen Inc. | 0.45% | Equity (US) | — |
| GEHC | GE HealthCare Technologies Inc. | 0.45% | Equity (US) | — |
| NTRA | Natera Inc. | 0.44% | Equity (US) | — |
| IQV | IQVIA Holdings Inc. | 0.44% | Equity (US) | — |
| CNC | Centene Corp. | 0.43% | Equity (US) | — |
| MTD | Mettler-Toledo International Inc. | 0.42% | Equity (US) | — |
| VEEV | Veeva Systems Inc. Class A | 0.39% | Equity (US) | — |
| UTHR | United Therapeutics Corp. | 0.38% | Equity (US) | — |
| RVMD | Revolution Medicines Inc. | 0.38% | Equity (US) | — |
| DXCM | DexCom Inc. | 0.38% | Equity (US) | — |
| DGX | Quest Diagnostics Inc. | 0.35% | Equity (US) | — |
| WST | West Pharmaceutical Services Inc. | 0.35% | Equity (US) | — |
| LH | Labcorp Holdings Inc. | 0.34% | Equity (US) | — |
| STE | STERIS plc | 0.34% | Equity (US) | — |
| ILMN | Illumina Inc. | 0.31% | Equity (US) | — |
Geographic Breakdown
Fund Holdings
VANGUARD HEALTH CARE INDEX FUND ·
NPORT-P period 2026-08-31
(filed 2026-04-28)
Net assets:
$20.27B
· 416 total positions
· equity 99.68%
· non-equity 0.19%
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | ELI LILLY & CO | Eli Lilly & Co | 12.54% | $2.54B |
| 2 | JOHNSON&JOHNSON | Johnson & Johnson | 8.74% | $1.77B |
| 3 | ABBVIE INC | AbbVie Inc | 6.08% | $1.23B |
| 4 | MERCK & CO | Merck & Co Inc | 4.58% | $928.9M |
| 5 | UNITEDHEALTH GRP | UnitedHealth Group Inc | 3.94% | $797.8M |
| 6 | AMGEN INC | Amgen Inc | 3.10% | $627.7M |
| 7 | ABBOTT LABS | Abbott Laboratories | 3.00% | $608.2M |
| 8 | THERMO FISHER | Thermo Fisher Scientific Inc | 2.92% | $591.1M |
| 9 | GILEAD SCIENCES | Gilead Sciences Inc | 2.74% | $555.1M |
| 10 | INTUITIVE SURGIC | Intuitive Surgical Inc | 2.68% | $542.2M |
| 11 | PFIZER INC | Pfizer Inc | 2.33% | $472.2M |
| 12 | DANAHER CORP | Danaher Corp | 2.01% | $407.7M |
| 13 | STRYKER CORP | Stryker Corp | 1.98% | $400.5M |
| 14 | VERTEX PHARM | Vertex Pharmaceuticals Inc | 1.89% | $382.6M |
| 15 | BRISTOL-MYER SQB | Bristol-Myers Squibb Co | 1.88% | $381.3M |
| 16 | MEDTRONIC PLC | Medtronic PLC | 1.86% | $376.3M |
| 17 | MCKESSON CORP | McKesson Corp | 1.82% | $368.9M |
| 18 | BOSTON SCIENTIFC | Boston Scientific Corp | 1.69% | $342.0M |
| 19 | CVS HEALTH CORP | CVS Health Corp | 1.50% | $304.4M |
| 20 | HCA HEALTHCARE I | HCA Healthcare Inc | 1.29% | $260.6M |
| 21 | REGENERON PHARM | Regeneron Pharmaceuticals Inc | 1.21% | $244.6M |
| 22 | THE CIGNA GROUP | Cigna Group/The | 1.15% | $232.4M |
| 23 | ELEVANCE HEALTH | Elevance Health Inc | 1.05% | $212.8M |
| 24 | CENCORA INC | Cencora Inc | 1.02% | $205.9M |
| 25 | ZOETIS INC | Zoetis Inc | 0.86% | $174.5M |
Showing top 25 of 411 equity holdings.
Daily issuer data also available
(2026-06-08)
via ETF Constituents
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +0.32% | 6 |
| Feb | -0.15% | 6 |
| Mar | -0.86% | 6 |
| Apr | -0.68% | 6 |
| May | -0.18% | 6 |
| Jun | +1.03% | 6 |
| Jul | +2.48% | 5 |
| Aug | -0.15% | 5 |
| Sep | -2.42% | 5 |
| Oct | +1.90% | 5 |
| Nov | +3.61% | 5 |
| Dec | +0.35% | 5 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $276.40
SMA 50: $274.17
SMA 200: $276.88
Current: $283.32
EMA 12: $278.95
EMA 26: $276.76
MACD: 2.1965 | Signal: 0.8116
BULLISH
ADX (14): 14.53
RANGE
+DI: 32.95
−DI: 20.37
Momentum Oscillators
RSI (14): 60.80
NEUTRAL
Stoch %K: 83.81
Stoch %D: 70.91
Williams %R: -22.85
Volume & Volatility
BB Upper: $285.11
BB Lower: $267.70
NEUTRAL
OBV: -7,972,448
Vol SMA 20: 235,406
Vol ROC: 67.03%
ATR: $4.14
True Range: $3.56
HV 20: 17.0%
HV 30: 15.9%
HV 60: 16.0%
Data Summary
Data Points: 500
Last Updated: 2026-06-08T21:15:15.859000
Date Range: 2024-06-10T00:00:00 – 2026-06-08T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Explore how two healthcare ETFs stack up in cost, yield, and strategy, with one fund emphasizing innovation and charitable impact.
The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. exposure, while the other adds global reach in a sector shaped by drug pricing,…
Options Activity
- IV Rank (30D)
- 12.3
- IV Rank (7D)
- 100
- Avg IV
- 22.5%
- Straddle (30D)
- $13.25
- Straddle (7D)
- $7.55
- P/C Volume
- 0.54
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 0.52
- Correlation (SPY)
- 43.2%
- R²
- 0.19
- Ann. Volatility
- 14.7%
- SPY Volatility
- 12.1%
Low volatility - stock moves less than market
Beta & Alpha Over Time
Constituent Performance
Click any bar to view the full quote for that stock.
Constituents
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|